MODERN VIEW OF THE ETIOPATHOGENESIS AND CLASSIFICATION OF ACNE SCARRING


Cite item

Full Text

Abstract

Acne vulgaris is a common chronic skin disease involving blockage and inflammation of pilosebaceous units. It has a genetic predisposition and sharply reduces the quality of patients’ life and the level of their social adaptation through the formation of conspicuous cosmetic defects in open areas of the skin. The processes of pathological scarring (atrophic, hypertrophic and keloid scars) is described in detail as one of the most severe consequences of acne vulgaris and its treatment. The problem is described from the modern point of view of the pathogenesis of acne vulgaris. Differential diagnosis between keloid and hypertrophic scars, as well as the most relevant approaches to classification and evaluation of severity of postacne scarring according to the valid international scales, are presented.

About the authors

Mariya N. Ostretsova

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: mostretsova@gmail.com
dermatologist, postgraduate student, of the department of skin and venereal deseases, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, 119991, Russian Federation Moscow, 119991, Russian Federation

References

  1. Ахтямов С.Н. Практическая дерматокосметология. Акне, рубцы постакне и акнеиформные дерматозы. М.: Медицина; 2010.
  2. Снарская Е.С., Кряжева С.С. Эпигаллокатехин-3-галлат (Эгаллохит) в коррекции симптомокомплекса постакне. Российский журнал кожных и венерических болезней. 2010; 6: 28-32.
  3. Олисова О.Ю., ред. Вульгарные угри. Методические рекомендации для клинических ординаторов и врачей. М.: I МГМУ им. И.М. Сеченова; 2016.
  4. Elsaie M.L. Hormonal treatment of acne vulgaris: an update. Clinical, cosmetic and investigational dermatology. 2016; 9(1): 241-8.
  5. Hosthota A., Bondade S., Basavaraja V. Impact of acne vulgaris on quality of life and self-esteem. Cutis. 2016; 97(2): 121-4.
  6. Thiboutot D., Gollnick H., Bettoli V., Dreno B., Kang S., Leyden J. J. et al.; Global Alliance to Improve Outcomes in Acne. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J. Am. Acad. Dermatol. 2009; 60(5, Suppl):: S1-50.
  7. Lynn D.D., Umari T., Dunnick C.A., Dellavalle R.P. The epidemiology of acne vulgaris in late adolescence. Adolesc. Health Med. Ther. 2016; 7: 13-25.
  8. Berlin D.J., Goldberg A.L. Acne and Rosacea Epidemiology, Diagnosis and Treatment. London: Manson Pub; 2012.
  9. Morris-Jones R. ABC of Dermatology. Chichester: John Wiley Sons; 2014.
  10. Олисова О.Ю., Вертиева Е.Ю. Комбинированная терапия акне. Consilium Medicum. Дерматология. 2013; 4: 22-5.
  11. Кунгуров Н.В., Кохан М.М., Зильберберг Н.В., Игликов В.А., Толстая А.И., Костырева И.Е., Волкова Н.В. Методические рекомендации: Терапия больных акне и постакне. Екатеринбург; АграфЕк; 2013: 24-42.
  12. Davis S.A., Huang K.E., Feldman S.R., Fleischer A.B., Huang W.W. Trends in ambulatory health care usage for adult acne. J. Cutan. Med. Surg. 2015; 19(4): 377-9.
  13. Di Landro A., Cazzaniga S., Cusano F., Bonci A., Carla C., Musumeci M.L., et al. Adult female acne and associated risk factors: Results of a multicenter case-control study in Italy. J. Am. Acad. Dermatol. 2016; 75(6): 1134-41. e1.
  14. Zeichner J.A., Baldwin H.E., Cook-Bolden F.E., Eichenfield L.F., Fallon-Friedlander S., Rodriguez D.A. Emerging issues in adult female acne. J. Clin. Aesthet. Dermatol. 2017; 10(1): 37-46.
  15. Dreno B., Khammari A., Orain N., Noray C., Merial-Kieny C., Mery S., et al. ECCA grading scale: an original validated acne scar grading scale for clinical practice in dermatology. Dermatology. 2007; 214(1): 46-51.
  16. Tan J.K., Tang J., Fung K., Gupta A.K., Thomas D.R., Sapra S., et al. Development and validation of a comprehensive acne severity scale. J. Cutan. Med. Surg. 2007; 11(6): 211-6.
  17. Aalami Harandi S., Balighi K., Lajevardi V., Akbari E. Subcision-suction method: a new successful combination therapy in treatment of atrophic acne scars and other depressed scars. J. Eur. Acad. Dermatol. Venereol. 2011; 25(1): 92-9.
  18. Перламутров Ю.Н., Ольховская К.Б. Терапия больных с тяжелой и средней степенью тяжести акне. Вестник дерматологии и венерологии. 2015; 3: 141-6.
  19. Шавловская О.А. Синдромы самоповреждения кожи (невротические экскориации). Consilium Medicum. Дерматология. 2015; 1: 31-6.
  20. Sarkar S., Patra P., Mridha K., Ghosh S.K., Mukhopadhyay A., Thakurta R.G. Personality disorders and its association with anxiety and depression among patients of severe acne: A cross-sectional study from Eastern India. Indian J. Psychiat. 2016; 58(4): 378-82.
  21. Halvorsen J.A., Stern R.S., Dalgard F., Thoresen M., Bjertness E., Lien L. Suicidal ideation, mental health problems, and social impairment are increased in adolescents with acne: a population-based study. J. Invest. Dermatol. 2011; 131(2): 363-70.
  22. Schrom K., Nagy T., Mostow E., Depression screening using health questionnaires in patients receiving oral isotretinoin for acne vulgaris. J. Am. Acad. Dermatol. 2016; 75(1): 237-9.
  23. Kang L., Liu J., An R., Huang J., Huang H., Yi Q. Depression in patients with facial acne vulgaris and the influential factors. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2015; 40(10): 1115-20.
  24. Tasoula E., Gregoriou S., Chalikias J., Lazarou D., Danopoulou I., Katsambas A., et al. The impact of acne vulgaris on quality of life and psychic health in young adolescents in Greece. Results of a population survey. An. Bras. Dermatol. 2012; 87(6): 862-9.
  25. Жильцова Е.Е., Ермошина Н.П. Психосоматические аспекты качества жизни у больных акне. Архив внутренней медицины. 2016; Спец. Вып.: 79-81.
  26. Музыченко А.П., Качук М.В., Особенности психосоматического статуса у пациентов с акнеформными дерматозами. ARS Medica. 2014; 25(1): 67-72.
  27. Nguyen C.M., Beroukhim K., Danesh M.J., Babikian A., Koo J., Leon A. The psychosocial impact of acne, vitiligo, and psoriasis: a review. Clin Cosmet Investig Dermatol. 2016;9:383-92
  28. Скрипкин Ю.К., Бутов Ю.С. Клиническая дерматовенерология: руководство для врачей. М.: Геотар-Медиа; 2009. т. 2
  29. Zaleski-Larsen L.A., Fabi S.G., McGraw T., Taylor M. Acne Scar Treatment: A Multimodality Approach Tailored to Scar Type. Dermatol. Surg. 2016; 42(Suppl. 2): S139-49
  30. Демина О.М., Потекаев Н.Н., Картелишев А.В. Клинико-патогенетические особенности и методы терапии поздних форм угревой болезни у женщин. Клиническая дерматология и венерология. 2015; 6: 125-9
  31. Layton A. The use of isotretinoin in acne. Dermatoendocrinology. 2009; 1(3): 162-9.
  32. Williams H.C., Dellavalle R.P., Garner S. Acne vulgaris. Lancet. 2012; 379(9813): 361-72.
  33. Davis E.C., Callender V.D. A review of acne in ethnic skin: pathogenesis, clinical manifestations, and management strategies. J. Clin. Aesthet. Dermatol. 2010; 3(4): 24-38.
  34. Голоусенко И.Ю., Перламутров Ю.Н. Лечение женщин с акне, яичниковой гиперандрогенией и инсулинорезистентностью. Вестник дерматологии и венерологии. 2013; 1: 22-7
  35. Gollnick H.P., Bettoli V., Lambert J., Araviiskaia E., Binic I., Dessinioti C., et al. A consensus-based practical and daily guide for the treatment of acne patients. J. Eur. Acad. Dermatol. Venereol. 2016; 30(9): 1480-90.
  36. Pham D.M., Boussouira B., Moyal D., Nguyen Q.L. Oxidization of squalene, a human skin lipid: a new and reliable marker of environmental pollution studies. Int. J. Cosmet. Sci. 2015; 37(4): 357-65.
  37. Белоусова Т.А., Горячкина М.В. Антибиотики в терапии угревой болезни: проблема рационального выбораю. Эффективная фармакотерапия. 2014; 4: 24-3.
  38. Ионеску М.А., Фейолей М., Эно Д., Волькенштейн П., Роберт Ж.,Лефёвр Л. Акне, микробиом и врожденный иммунитет. Российский журнал кожных и венерических болезней. 2016; 19(5): 279-82.
  39. Ingham E., Eady E.A., Goodwin C.E., Cove J.H., Cunliffe W.J. Pro-inflammatory levels of interleukin-1 alpha-like bioactivity are present in the majority of open comedones in acne vulgaris. J. Invest. Dermatol. 1992; 98(6): 895-901.
  40. Do T.T., Zarkhin S., Orringer J.S. Computer-assisted alignment and tracking of acne lesions indicate that most inflammatory lesions arise from comedones and de novo. J. Am. Acad. Dermatol. 2008; 58(4): 603-8.
  41. Kircik L.H. Re-evaluating treatment targets in acne vulgaris: adapting to a new understanding of pathophysiology. J. Drugs Dermatol. 2014; 13(6): s 57-60.
  42. Rocha M.A., Costa C.S., Bagatin E. Acne vulgaris: an inflammatory disease even before the onset of clinical lesions. Inflamm Allergy Drug Targets. 2014; 13(3): 162-7.
  43. Leeming J., Holland K., Cunliffe W.J. The microbial colonization of inflamed acne vulgaris lesions. Br. J. Dermatol. 1988; 118(2): 203-8.
  44. Anttila H.S., Reitamo S., Erkko P., Miettiene A., Didiejean L., Saurat J.H. Membrane and cytosolic interleukin-1 alpha and beta in normal human epidermal cells: variability of epitope exposure in immunohistochemistry. J. Invest. Dermatol. 1990; 95(1): 31-8.
  45. Anttila H.S.; Reitamo S.; Saurat J.H. Interleukin-1 immunoreactivity in sebaceous glands. Br. J. Dermatol. 1992; 127(6): 585-8.
  46. Fabbrocini G., Annunziata M.C., D’Arco V., De Vita V., Lodi G., Mauriello M.C., et al. Acne scars: pathogenesis, classification and treatment. Dermatol. Res. Pract. 2010; 2010: 893080.
  47. Portou M.J., Baker D., Abraham D., Tsui J. The innate immune system, toll-like receptors and dermal wound healing: A review. Vascul. Pharmacol. 2015; 71: 31-6.
  48. Roupe K.M., Nybo M., Sjobring U., Alberius P., Schmidtchen A., Sorensen O.E.: Injury is a major inducer of epidermal innate immune responses during wound healing. J. Invest. Dermatol. 2010; 130(4): 1167-7.
  49. Huang C., Murphy G.F., Akaishi S., Ogawa R. Keloids and hypertrophic scars: update and future directions. Plast. Reconstr. Surg. Glob. Open. 2013; 1(4): e25.
  50. Виссарионов В.А., Стенько А.Г., Змазова В.Г., Коновалова Т.А. Лечение рубцовых повреждений: препарат Лонгидаза 3000 МЕ. Вестник эстетической медицины. 2008; 7(4): 46-51.
  51. Снарская Е.С. Комплексная терапия эстетических дефектов кожи в результате патологического фиброгенеза. Consilium medicum. Дерматология. 2013; 2-3: 15-20.
  52. Неробеев А.И. Клинический протокол по диагностике и лечению пациентов с рубцовыми поражениями кожи. М.; 2014. Available at: mosgorzdrav.ru/uploads/imperavi/ru-RU/Рубцовые%20поражения%20кожи.doc.
  53. Jacob C.I., Dover J.S., Kaminer M.S. Acne scarring: a classification system and review of treatment options. J. Am. Acad. Dermatol. 2001; 45(1): 109-117.
  54. Goodman G.J., Baron J.A. Postacne scarring: a qualitative global scarring grading system. Dermatol. Surg. 2006; 32(12): 1458-66.
  55. Goodman G.J., Baron J.A. Postacne scarring - a quantitative global scarring grading system. J. Cosmet. Dermatol. 2006; 5(1): 48-52.
  56. Kang S., Lozada V.T., Bettoli V., Tan J., Rueda M.J., Layton A., et al. New Atrophic Acne Scar Classification: reliability of assessments based on size, shape, and number. J. Drugs Dermatol. 2016; 15(6): 693-702.

Copyright (c) 2017 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies